Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
flecainide
Description:
A class Ic antiarrhythmic medication used to prevent and treat certain abnormal heart rhythms.
Primary topic:
Cardiac electrophysiology and arrhythmias (38%)
Related topics:
Cardiac electrophysiology and arrhythmias (38%),
Cardiac Arrhythmias and Treatments (16%),
Atrial Fibrillation Management and Outcomes (15%)
Wikidata ID:
wiki/Q421381
OpenAlex ID:
keywords/flecainide
Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial Infarction
1989
·
The Cardiac Arrhythmia Suppression Trial (CAST) Investigators
·
New England Journal of Medicine
·
3,324
Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo: The Cardiac Arrhythmia Suppression Trial
1991
·
Debra S. Echt
, Philip R. Liebson
, et al.
·
New England Journal of Medicine
·
3,287
PDF
The Cardiac Arrhythmia Suppression Trial Investigators: Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression After Myocardial Infarction.
1990
·
Meg Weir
·
Cardiopulmonary Physical Therapy Journal
·
1,061
Treatment of Atrial Fibrillation With Antiarrhythmic Drugs or Radiofrequency Ablation: Two Systematic Literature Reviews and Meta-Analyses
2009
·
Hugh Calkins
, Matthew R. Reynolds
, et al.
·
Circulation Arrhythmia and Electrophysiology
·
872
Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
1994
·
S Grissmer
, A N Nguyen
, et al.
·
Molecular Pharmacology
·
789
Sodium Channel Blockers Identify Risk for Sudden Death in Patients With ST-Segment Elevation and Right Bundle Branch Block but Structurally Normal Hearts
2000
·
Ramon Brugada
, Josep Brugada
, et al.
·
Circulation
·
763
A Randomized Trial of Circumferential Pulmonary Vein Ablation Versus Antiarrhythmic Drug Therapy in Paroxysmal Atrial Fibrillation
2006
·
Carlo Pappone
, Giuseppe Augello
, et al.
·
Journal of the American College of Cardiology
·
703
PDF
Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans
2009
·
Hiroshi Watanabe
, Nagesh Chopra
, et al.
·
Nature Medicine
·
618
Common molecular determinants of local anesthetic, antiarrhythmic, and anticonvulsant block of voltage-gated Na+ channels.
1996
·
D S Ragsdale
, J C McPhee
, et al.
·
Proceedings of the National Academy of Sciences
·
499
The Brugada syndrome: clinical, electrophysiologic and genetic aspects
1999
·
Ihor Gussak
, Charles Antzelevitch
, et al.
·
Journal of the American College of Cardiology
·
495
PDF
Outpatient Treatment of Recent-Onset Atrial Fibrillation with the “Pill-in-the-Pocket” Approach
2004
·
Paolo Alboni
, Giovanni L. Botto
, et al.
·
New England Journal of Medicine
·
490
PDF
Flecainide Therapy Reduces Exercise-Induced Ventricular Arrhythmias in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia
2011
·
Christian van der Werf
, Prince J. Kannankeril
, et al.
·
Journal of the American College of Cardiology
·
410
PDF
Short QT syndrome: pharmacological treatment
2004
·
Fiorenzo Gaita
, Carla Giustetto
, et al.
·
Journal of the American College of Cardiology
·
359
PDF
Arrhythmic disorder mapped to chromosome 1q42–q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts
1999
·
Heikki Swan
, Kirsi Piippo
, et al.
·
Journal of the American College of Cardiology
·
349
PDF
Structure of the Cardiac Sodium Channel
2019
·
Daohua Jiang
, Hui Shi
, et al.
·
Cell
·
343
PDF
Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation
2015
·
Gaetano M. De Ferrari
, Veronica Dusi
, et al.
·
Circulation
·
303
PDF
Fetal tachycardias: management and outcome of 127 consecutive cases
1998
·
J M Simpson
, G K Sharland
·
Heart
·
300
PDF
Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide
2015
·
Juan Tamargo
, Jean-Yves Le Heuzey
, et al.
·
European Journal of Clinical Pharmacology
·
295
PDF
Prevention of symptomatic recurrences of paroxysmal atrial fibrillation in patients initially tolerating antiarrhythmic therapy. A multicenter, double-blind, crossover study of flecainide and placebo with transtelephonic monitoring. Flecainide Supraventricular Tachycardia Study Group.
1989
·
J L Anderson
, E M Gilbert
, et al.
·
Circulation
·
290
Antiarrhythmic Drugs for Maintaining Sinus Rhythm After Cardioversion of Atrial Fibrillation: A Systematic Review of Randomized Controlled Trials
2006
·
Carmelo Lafuente-Lafuente
, Stéphane Mouly
, et al.
·
Archives of Internal Medicine
·
286
Clinical significance of the sparteine/debrisoquine oxidation polymorphism
1989
·
K. Br�sen
, L. F. Gram
·
European Journal of Clinical Pharmacology
·
281
Flecainide: Its proarrhythmic effect and expected changes on the surface electrocardiogram
1984
·
Joel Morganroth
, Leonard N. Horowitz
·
The American Journal of Cardiology
·
281
The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm
1990
·
Maarten J. Suttorp
, J.Herre Kingma
, et al.
·
Journal of the American College of Cardiology
·
280
PDF
Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter
1991
·
Harry J. Crijns
, Isabelle C. Van Gelder
, et al.
·
The American Journal of Cardiology
·
276
Kinetics of onset of rate-dependent effects of Class I antiarrhythmic drugs are important in determining their effects on refractoriness in guinea-pig ventricle, and provide a theoretical basis for their subclassification
1983
·
T. J CAMPBELL
·
Cardiovascular Research
·
274
Show more works
View as search
Works count:
4,522
Citation count:
77,550
Year
Topic
Type